Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell―Based Vaccination in Metastatic MelanomaAARNTZEN, Erik H. J. G; BOL, Kalijn; SCHREIBELT, Gerty et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 23, pp 6102-6110, issn 0008-5472, 9 p.Article

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide usedLEWSTERHUIS, W. Joost; SCHREIBELT, Gerty; DE VRIES, I. Jolanda M et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 2, pp 249-260, issn 0340-7004, 12 p.Article

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3⁺ myeloid dendritic cellsSCHREIBELT, Gerty; KLINKENBERG, Lieke J. J; CRUZ, Luis J et al.Blood. 2012, Vol 119, Num 10, pp 2284-2292, issn 0006-4971, 9 p.Article

Route of Administration Modulates the Induction of Dendritic Cell Vaccine―Induced Antigen-Specific T Cells in Advanced Melanoma PatientsJOOST LESTERHUIS, W; DE VRIES, I. Jolanda M; VAN ROSSUM, Michelle M et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5725-5735, issn 1078-0432, 11 p.Article

In situ Expression of Tumor Antigens by Messenger RNA―Electroporated Dendritic Cells in Lymph Nodes of Melanoma PatientsSCHUURHUIS, Danita H; VERDIJK, Pauline; BONENKAMP, Johannes J et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 2927-2934, issn 0008-5472, 8 p.Article

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cellsSCHUURHUIS, Danita H; LESTERHUIS, W. Joost; PUNT, Cornelis J. A et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 7, pp 1109-1115, issn 0340-7004, 7 p.Article

Targeting CD4⁺ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell―Based VaccinationAARNTZEN, Erik H. J. G; DE VRIES, I. Jolanda M; SCHADENDORF, Dirk et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 1, pp 19-29, issn 0008-5472, 11 p.Article

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4⁺ and CD8⁺ T Cells Responses in Stage III and IV Melanoma PatientsAARNTZEN, Erik H. J. G; SCHREIBELT, Gerty; SCHUURHUIS, Danita H et al.Clinical cancer research (Print). 2012, Vol 18, Num 19, pp 5460-5470, issn 1078-0432, 11 p.Article

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E₂ results in high interleukin-12 production and cell migrationINGE BOULLART, A. C; AARNTZEN, Erik H. J. G; KRAMER, Matthijs et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 11, pp 1589-1597, issn 0340-7004, 9 p.Article

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma PatientsTEL, Jurjen; AARNTZEN, Erik H. J. G; WINKELS, Gregor et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 3, pp 1063-1075, issn 0008-5472, 13 p.Article

Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cellsSCHREIBELT, Gerty; BENITEZ-RIBAS, Daniel; SCHUURHUIS, Danita et al.Blood. 2010, Vol 116, Num 4, pp 564-574, issn 0006-4971, 11 p.Article

Toll-like receptor expression and function in human dendritic cel subsets: implications for dendritic cell-based anti-cancer immunotherapySCHREIBELT, Gerty; TEL, Jurjen; SLIEPEN, Kwinten H. E. W. J et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 10, pp 1573-1582, issn 0340-7004, 10 p.Article